I agree that this site is using cookies. You can find further informations here.
X
Chughlay, Mohamed Farouk
16  results:
Search for persons X
?
1

Safety and efficacy of four drug regimens versus standard-o..:

Chandiwana, Nomathemba ; Kruger, Chelsea ; Johnstone, Hilary...
eBioMedicine.  86 (2022)  - p. 104322 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Chemoprotective Antimalarial Activity of P218 against Plasm..:

Chughlay, Mohamed Farouk ; El Gaaloul, Myriam ; Donini, Cristina...
The American Journal of Tropical Medicine and Hygiene.  104 (2021)  4 - p. 1348-1358 , 2021
Link: https://doi.org/10.4269/..
 
?
3

Concentration‐QT modelling of the novel DHFR inhibitor P218..:

Täubel, Jӧrg ; Lorch, Ulrike ; Ferber, Georg...
British Journal of Clinical Pharmacology.  88 (2021)  1 - p. 128-137 , 2021
Link: https://doi.org/10.1111/..
 
?
4

N‐acetylcysteine for non‐paracetamol drug‐induced liver inj..:

Chughlay, Mohamed Farouk ; Kramer, Nicole ; Spearman, C. Wendy..
British Journal of Clinical Pharmacology.  81 (2016)  6 - p. 1021-1029 , 2016
Link: https://doi.org/10.1111/..
 
?
5

N-acetylcysteine for non-paracetamol drug-induced liver inj..:

Chughlay, Mohamed Farouk ; Kramer, Nicole ; Werfalli, Mahmoud...
Systematic Reviews.  4 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
6

Concentration‐QT modelling of the novel DHFR inhibitor P218..:

Täubel, Jӧrg ; Lorch, Ulrike ; Ferber, Georg...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292718/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

N‐acetylcysteine for non‐paracetamol drug‐induced liver inj..:

Chughlay, Mohamed Farouk ; Kramer, Nicole ; Spearman, C. Wendy..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876182/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
8

N-Acetylcysteine for non-paracetamol drug-induced liver inj..:

Chughlay, Mohamed Farouk
http://hdl.handle.net/11427/20294.  , 2016
Link: http://hdl.handle.net/11..
 
?
9

Safety and efficacy of four drug regimens versus standard-o..:

Nomathemba Chandiwana ; Chelsea Kruger ; Hilary Johnstone...
http://www.sciencedirect.com/science/article/pii/S2352396422005047.  , 2022
Link: https://doi.org/10.1016/..
 
?
10

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic..:

Chughlay, M. Farouk ; Barnes, Karen I. ; El Gaaloul, Myriam...
Antimicrobial Agents and Chemotherapy.  66 (2022)  1 - p. , 2022
Link: https://doi.org/10.1128/..
 
?
11

Rechallenge after anti-tuberculosis drug-induced liver inju..:

Moosa, Muhammed Shiraz ; Maartens, Gary ; Gunter, Hannah...
Southern African Journal of HIV Medicine.  23 (2022)  1 - p. , 2022
Link: https://doi.org/10.4102/..
 
?
12

Safety, Tolerability, and Parasite Clearance Kinetics in Co..:

Chughlay, M. Farouk ; Chalon, Stephan ; El Gaaloul, Myriam...
The American Journal of Tropical Medicine and Hygiene.  107 (2022)  4 - p. 804-814 , 2022
Link: https://doi.org/10.4269/..
 
?
13

Unanticipated CNS Safety Signal in a Placebo‐Controlled, Ra..:

Chalon, Stephan ; Chughlay, M. Farouk ; Abla, Nada...
Clinical Pharmacology & Therapeutics.  111 (2021)  4 - p. 867-877 , 2021
Link: https://doi.org/10.1002/..
 
?
14

First‐in‐human clinical trial to assess the safety, tolerab..:

Chughlay, M. Farouk ; Rossignol, Emilie ; Donini, Cristina...
British Journal of Clinical Pharmacology.  86 (2020)  6 - p. 1113-1124 , 2020
Link: https://doi.org/10.1111/..
 
?
15

A Randomized Controlled Trial of Intravenous N-Acetylcystei..:

Moosa, Muhammed Shiraz ; Maartens, Gary ; Gunter, Hannah...
Clinical Infectious Diseases.  73 (2020)  9 - p. e3377-e3383 , 2020
Link: https://doi.org/10.1093/..
 
1-15